Sclerosis
Showing 5176 - 5200 of 5,979
Multiple Sclerosis Trial in Safed (Blood testing)
Unknown status
- Multiple Sclerosis
- Blood testing
-
Safed, IsraelZIV Medical Center
Dec 2, 2013
Sickle Cell Disease Trial in Paris (RAS Inhibitors)
Completed
- Sickle Cell Disease
- RAS Inhibitors
-
Paris, FranceCentre de la Drépanocytose, Service de Médecine Interne. Hôpital
Jun 17, 2015
Multiple Sclerosis: MicroRNA and Antigen-Presenting Cells
Completed
- Multiple Sclerosis
-
New Brunswick, New JerseyRutgers-RWJMS
Nov 19, 2013
Overactive Bladder, Urinary Incontinence Trial in Miami (Botox)
Withdrawn
- Overactive Bladder
- Urinary Incontinence
-
Miami, FloridaMiami VA Medical Center
Jun 25, 2015
Raynaud's Phenomenon, Skin Necrosis Trial in Freiburg (Tracleer, Prostavasin)
Unknown status
- Raynaud's Phenomenon
- Skin Necrosis
-
Freiburg, Baden Württemberg, GermanyUniversity Freiburg
Dec 12, 2014
Safety of MenACWY-CRM Vaccination in Adolescents
Completed
- Meningococcal Disease
- MenACWY-CRM
-
Riverside, California
- +2 more
Feb 25, 2015
Multiple Sclerosis Trial in Albany, Latham (Angioplasty, Observation)
Terminated
- Multiple Sclerosis
- Angioplasty
- Observation
-
Albany, New York
- +1 more
Nov 25, 2013
Myocardial Infarction, Cardiovascular Death, Atherothrombosis Trial in Worldwide (Ticagrelor 90 mg, Ticagrelor 60 mg, Ticagrelor
Completed
- Myocardial Infarction
- +3 more
- Ticagrelor 90 mg
- +2 more
-
Alexander City, Alabama
- +846 more
Dec 18, 2015
Cardiorenal Syndrome, Chronic Allograft Nephropathy Trial in Rotterdam, Yekaterinburg (Paricalcitol, Calcitriol,
Completed
- Cardiorenal Syndrome
- Chronic Allograft Nephropathy
- Paricalcitol
- +3 more
-
Rotterdam, South Holland, Netherlands
- +1 more
May 14, 2015
Bayer/Cognitive Assessments With Multiple Sclerosis Subjects
Completed
- Multiple Sclerosis, Relapsing-remitting
- Multiple Sclerosis, Secondary Progressive
-
Louisville, KentuckyUniversity of Louisville
Oct 31, 2013
Optic; Neuritis, With Demyelination Trial in Vienna (Amiloride hydrochlorothiazide, Sugar pill)
Unknown status
- Optic; Neuritis, With Demyelination
- Amiloride hydrochlorothiazide
- Sugar pill
-
Vienna, AustriaMedical University of Vienna, Department of Neurology
May 8, 2015
Family Blood Pressure Program - HyperGEN
Completed
- Cardiovascular Diseases
- +2 more
- (no location specified)
Oct 6, 2015
Amyotrophic Lateral Sclerosis Trial in Tehran (Granulocyte Colony Stimulating Factor, Placebo)
Completed
- Amyotrophic Lateral Sclerosis
- Granulocyte Colony Stimulating Factor
- Placebo
-
Tehran, Iran, Islamic Republic ofIranian Neurology Research Center of Tehran University of Medica
Nov 10, 2013
Diabetes, Type 2 Trial in Worldwide (BI 10773 low dose, Placebo BI 10773 high dose, BI 10773 high dose)
Completed
- Diabetes Mellitus, Type 2
- BI 10773 low dose
- +3 more
-
Birmingham, Alabama
- +614 more
Apr 7, 2016
Sodium Intake in Multiple Sclerosis
Completed
- Multiple Sclerosis
-
Buenos Aires, ArgentinaFLENI
Oct 21, 2013
Cognition Disorders Trial in United States (Cognitive Strategy Training, Placebo comparison group)
Completed
- Cognition Disorders
- Cognitive Strategy Training
- Placebo comparison group
-
San Diego, California
- +3 more
Jan 14, 2015
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Glatiramer Acetate, Placebo)
Terminated
- Relapsing-Remitting Multiple Sclerosis
- Glatiramer Acetate
- Placebo
-
Cullman, Alabama
- +168 more
Feb 19, 2014
GVHD Trial in Petach Tikva (Oral Cannabidiol)
Unknown status
- Graft Versus Host Disease
- Oral Cannabidiol
-
Petach Tikva, IsraelDavidoff Cancer Center, Beilin hospital, Rabin medical center
Jun 18, 2015
Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease Trial in United States (coenzyme Q10, Placebo)
Completed
- Amyotrophic Lateral Sclerosis
- Lou Gehrig's Disease
- coenzyme Q10
- Placebo
-
Little Rock, Arkansas
- +18 more
Jan 28, 2014
Multiple Sclerosis Trial in Worldwide (Rebif® New Formulation (RNF) using RebiSmartTM)
Completed
- Multiple Sclerosis
- Rebif® New Formulation (RNF) using RebiSmartTM
-
Rockland, Massachusetts
- +5 more
Oct 21, 2013